Business · 27/10/2015Updated: 10/17/2026 · 1 min read
FDA Establishes Public Docket for Bulk Drug Substances for Compounding Drug Products Under Section 503B of the FD&C Act
Summary
The FDA is creating a public docket to collect nominations for bulk drug substances that can be used to compound drug products in accordance with the FD&C Act, and to receive comments on previously nominated substances
Original source language: Federal Register — Food and Drug AdministrationOpen original release →